Hemophilia Treatment and Patient Care

Hemophilia Treatment and Patient Care: Innovations and Shared Decision-Making

Patients with hemophilia depend on you for more than simply controlling bleeding episodes. By completing this free, online suite of courses, you can help your patients navigate the available and soon-to-be available therapies and examine the challenges associated with these treatments.

Learning Objectives

Explain the evolving hemophilia treatment landscape.
Evaluate the potential clinical applications of novel approaches like gene therapy and rebalancing agents.

Explore the current treatment landscape for hemophilia, including an introduction to Hemophilia A and B. Review traditional therapies such as conventional factor replacement and extended half-life (EHL) coagulation factor concentrates. Examine the challenges associated with these treatments and discuss the key reasons driving the development of new therapeutic approaches.

Enroll in Module 1

Learning Objectives

Explain how to collaborate with patients using Shared Decision-making (SDM).
Describe how gold standard practices can be incorporated into all types of hemophilia patient care.
Apply healthcare strategies to provide effective, personalized, and welcoming patient care.

Develop tools for personalized care of hemophilia patients and facilitate shared decision making between patients and healthcare providers. You’ll learn how to integrate this powerful change in paradigm for optimal care of patients with hemophilia and their families.

Enroll in Module 2

Content Experts

Dr. Paula James, Division of Hematology, Queen's University
Dr. Eleftherios Soleas, Office of Professional Development and Educational Scholarship, Queen's University
Dr. Laura Wheaton, Division of Hematology and Department of Pediatrics, Queen's University
Dr. Jennifer Leung, Division of Hematology, Queen's University
Nurse Lisa Thibeault, Kingston Health Sciences Centre
Dr. David Lillicrap, Division of Hematology, Queen's University
Nurse Megan Chaigneau, Kingston Health Sciences Centre

Who should take these courses?

Specialist physicians, nurses, nurse practitioners, and members of interprofessional teams who treat patients with hemophilia.

Accreditation

Credits for Royal College Specialists: This program is an accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and approved by the Queen’s University CPD Team. You may claim a maximum of 0.75 hours (credits are automatically calculated).

Hemophilia Treatment and Patient Care

This Patient Journey Guide Explains:

Review or Download this Guide